Download PDF
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2020; 7(03): 128-139
DOI: 10.1055/s-0040-1714648
Review Article

The Neurocritical Care Society of India (NCSI) and the Indian Society of Neuroanaesthesiology and Critical Care (ISNACC) Joint Position Statement and Advisory on the Practice of Neurocritical Care during the COVID-19 Pandemic

Ponniah Vanamoorthy
1   Department of Neuroanaesthesiology and Neurocritical Care, Institute of Neurosciences and Spinal Disorders, MGM Healthcare, Chennai, Tamil Nadu, India
,
Gyaninder P. Singh 
2   Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India
,
Prasanna U. Bidkar
3   Division of Neuroanaesthesiology, Department of Anesthesiology and Critical care, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India
,
Ranadhir Mitra
4   Department of Neuroanesthesia and Neurocritical Care, Care Hospital, Bhubaneswar, Odisha, India
,
Kamath Sriganesh
5   Department of Neuroanaesthesiology and Neurocritical Care, National Institute of Mental Health and Neuro-Sciences, Bengaluru, Karnataka, India
,
Siddharth Chavali 
6   Department of Neurosciences, Aditya Birla Memorial Hospital, Pune, Maharashtra, India
,
Radhakrishnan Muthuchellapan
5   Department of Neuroanaesthesiology and Neurocritical Care, National Institute of Mental Health and Neuro-Sciences, Bengaluru, Karnataka, India
,
Venkatesh H. Keshavan
7   Department of Neuroanaesthesiology and Neurocritical Care, Apollo Hospitals, Bengaluru, Karnataka, India
,
Saurabh Anand
8   Department of Neuroanaesthesia and Neurocritical Care, Artemis Hospital, Gurugram, Haryana, India
,
Keshav Goyal
2   Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India
,
Rahul Yadav
9   Department of Anaesthesiology and Critical Care, INHS Asvini, Mumbai, Maharashtra, India
,
Girija P. Rath 
2   Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India
,
Shashi Srivastava
10   Department of Anesthesiology and Critical Care, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) has rapidly spread across the world including India. Management of patients complicated with neurological illness requiring neurocritical care is challenging during this time. Patients with neurological disease may develop COVID-19 infection or there could be independent neurological manifestations of COVID-19. Critically ill neurological patients are more vulnerable to contracting SARS-CoV-2 infection. Also, neurological patients with comorbidities and multisystem involvement are at increased risk of adverse outcomes. Though SARS-CoV-2 predominantly affects the pulmonary system, it can complicate the assessment and management of neurological patients. With increasing COVID-19 numbers, the hospitalizations of both non-COVID and COVID-19 neurological patients will bring significant strain on the hospital and neurocritical care facilities. Streamlining work pattern, understanding the pathophysiology of COVID-19 and its impact on neurological function, establishing general and specific neurocritical care management strategies, ensuring protection and well-being of health care providers, and implementing effective infection control policies are key elements of efficient neurocritical care management during this pandemic. This joint position statement and advisory on the practice of neurocritical care during the COVID-19 pandemic by the Neurocritical Care Society of India and the Indian Society of Neuroanaesthesiology and Critical Care has been developed to guide clinicians providing care to the critically ill neurological patients in the neurocritical care unit during the current pandemic. As the situation from this novel disease is rapidly evolving, readers must constantly update themselves with newly emerging evidence to provide the best possible care to the critically ill neurological patients.

Keywords

COVID-19 pandemic - SARS-CoV-2 - neurological manifestations - critically ill neurological patients - neurocritical care management


Publication History

Article published online:
13 July 2020

© 2020. Indian Society of Neuroanaesthesiology and Critical Care. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 2020; DOI: 10.1164/rccm.202006-2157CP.
    CrossrefPubMedGoogle Scholar
  • 2 Xiao AT, Tong YX, Zhang S. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol 2020. DOI: 10.1002/jmv.25855.
    CrossrefPubMedGoogle Scholar
  • 3 Goh KJ, Wong J, Tien JC. et al. Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies. Crit Care 2020; 24 (01) 215
    CrossrefPubMedGoogle Scholar
  • 4 Martland AM, Huffines M, Henry K. Surge priority planning COVID-19: critical care staffing and nursing considerations. CHEST 2020. Available at: http://www.chestnet.org/Guidelines-and-Resources/Resources/Surge-Priority-Planning-COVID-19-Critical-Care-Staffing-and-Nursing-Considerations. Accessed June 10, 2020
    PubMed
  • 5 New WHO tools launched to help hospitals manage surge in COVID-19 patients. April 8, 2020. Available at: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/4/new-who-tools-launched-to-help-hospitals-manage-surge-in-covid-19-patients. Accessed June 10, 2020
    PubMed
  • 6 List N. Disinfectants for Use Against SARS-CoV-2 (COVID-19). 2020. Available at: https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2. Accessed June 15, 2020
    PubMed
  • 7 COVID-19. Guidelines on disinfection of common public places including offices. 2020. Available at: https://www.mohfw.gov.in/pdf/Guidelinesondisinfectionofcommonpublicplacesincludingoffices.pdf. Accessed June 15, 2020
    PubMed
  • 8 Instructions to all major and minor ports for dealing with novel coronavirus (COVID-19) pandemic. Cleaning agents and disinfectants. 2020. Available at: https://www.mohfw.gov.in/pdf/DGSOrder04of2020.pdf. Accessed June 15, 2020
    PubMed
  • 9 Coronavirus Disease. 2019 (COVID-19): Standard Operating Procedure (SOP) for transporting a suspectirmed case of COVID-19. 2020. Available at: https://www.mohfw.gov.in/pdf/StandardOperatingProcedureSOPfortransportingasuspectorconfirmedcaseofCOVID19.pdf. Accessed June 10, 2020
    PubMed
  • 10 Guidelines for disinfection of quarantine facility (for COVID-19). 2020. Available at: https://ncdc.gov.in/WriteReadData/l892s/89168637271584172711.pdf. Accessed June 15, 2020
    PubMed
  • 11 Novel Coronavirus Disease. 2019 (COVID-19): Guidelines on rational use of Personal Protective Equipment. 2020. Available at: https://www.mohfw.gov.in/pdf/Guideli0nesonrationaluseofPersonalProtectiveEquipment.pdf. Accessed June 10, 2020
    PubMed
  • 12 Novel Coronavirus Disease. 2019 (COVID-19): Additional guidelines on rational use of Personal Protective Equipment (setting approach for Health functionaries working in non-COVID areas). 2020. Available at: https://www.mohfw.gov.in/pdf/AdditionalguidelinesonrationaluseofPersonalProtectiveEquipmentsettingapproachforHealthfunctionariesworkinginnonCOVIDareas.pdf. Accessed June 10, 2020
    PubMed
  • 13 National guidelines for infection prevention and control in healthcare facilities. 2020. Available at: https://www.mohfw.gov.in/pdf/National%20Guidelines%20for%20IPC%20in%20HCF%20-%20final%281%29.pdf. Accessed June 10, 2020
    PubMed
  • 14 Using Personal Protective Equipment (PPE). 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/using-ppe.html. Accessed June 10, 2020
    PubMed
  • 15 Steps to put on personal protective equipment (PPE). 2020. Available at: https://www.who.int/csr/disease/ebola/put_on_ppequipment.pdf. Accessed June 10, 2020
    PubMed
  • 16 El-Boghdadly K, Wong DJN, Owen R. et al. Risks to healthcare workers following tracheal intubation of patients with COVID-19: a prospective international multicentre cohort study. Anaesthesia 2020: DOI: 10.1111/anae.15170.
    CrossrefPubMedGoogle Scholar
  • 17 World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance. March 13, 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2. Accessed June 16, 2020
    PubMed
  • 18 Alhazzani W, Møller MH, Arabi YM. et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46 (05) 854-887
    CrossrefPubMedGoogle Scholar
  • 19 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; DOI: 10.1001/jama.2020.2648.
    CrossrefPubMedGoogle Scholar
  • 20 NIH-Coronavirus Disease. 2019 (COVID-19) Treatment Guideline. 2020. Available at: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf. Accessed June 16, 2020
    PubMed
  • 21 van den Boom W, Hoy M, Sankaran J. et al. The search for optimal oxygen saturation targets in critically ill patients: observational data from large ICU databases. Chest 2020; 157 (03) 566-573
    CrossrefPubMedGoogle Scholar
  • 22 Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020: 10.1001/jamainternmed.2020.0994
    PubMed
  • 23 Cornejo RA, Díaz JC, Tobar EA. et al. Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2013; 188 (04) 440-448
    CrossrefPubMedGoogle Scholar
  • 24 Munshi L, Del Sorbo L, Adhikari NKJ. et al. Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2017; 14 (Suppl. 04) S280-S288
    CrossrefPubMedGoogle Scholar
  • 25 Bloomfield R, Noble DW, Sudlow A. Prone position for acute respiratory failure in adults. Cochrane Database Syst Rev 2015; (11) CD008095
    PubMedGoogle Scholar
  • 26 Mora-Arteaga JA, Bernal-Ramírez OJ, Rodríguez SJ. The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and meta-analysis. Med Intensiva 2015; 39 (06) 359-372
    PubMedGoogle Scholar
  • 27 Lee JM, Bae W, Lee YJ, Cho YJ. The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: updated study-level meta-analysis of 11 randomized controlled trials. Crit Care Med 2014; 42 (05) 1252-1262
    CrossrefPubMedGoogle Scholar
  • 28 Roth C, Ferbert A, Deinsberger W. et al. Does prone positioning increase intracranial pressure? A retrospective analysis of patients with acute brain injury and acute respiratory failure. Neurocrit Care 2014; 21 (02) 186-191
    CrossrefPubMedGoogle Scholar
  • 29 Nekludov M, Bellander BM, Mure M. Oxygenation and cerebral perfusion pressure improved in the prone position. Acta Anaesthesiol Scand 2006; 50 (08) 932-936
    CrossrefPubMedGoogle Scholar
  • 30 Yang X, Yu Y, Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8 (05) 475-481
    CrossrefPubMedGoogle Scholar
  • 31 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061-1069
    CrossrefPubMedGoogle Scholar
  • 32 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229) 1054-1062
    Google Scholar
  • 33 Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46 (05) 846-848
    CrossrefPubMedGoogle Scholar
  • 34 Guan WJ, Ni ZY, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
    CrossrefPubMedGoogle Scholar
  • 35 Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;e201127. Doi: 10.1001/jamaneurol.2020.1127
    PubMed
  • 36 Oxley TJ, Mocco J, Majidi S. et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020; 382 (20) e60
    CrossrefPubMedGoogle Scholar
  • 37 Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 2020; 12 (03) e7352
    PubMedGoogle Scholar
  • 38 Hepburn M, Mullaguri N, George P, et al. Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care 2020: 10.1007/s12028-020-01006-1
    PubMed
  • 39 Louis S, Dhawan A, Newey C, et al. Continuous electroencephalography (cEEG) characteristics and acute symptomatic seizures in COVID-19 patients. medRxiv; 2020: 10.1101/2020.05.26.20114033
    PubMed
  • 40 Li Y, Wang M, Zhou Y. et al. Acute cerebrovascular disease following covid-19: a single center, retrospective, observational study. Lancet 2020; DOI: 10.2139/ssrn.3550025.
    CrossrefPubMedGoogle Scholar
  • 41 Yaghi S, Ishida K, Torres J. et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke 2020; 51 (07) 2002-2011
    CrossrefPubMedGoogle Scholar
  • 42 Varga Z, Flammer AJ, Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395 (10234) 1417-1418
    CrossrefPubMedGoogle Scholar
  • 43 Michot JM, Albiges L, Chaput N. et al. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. Ann Oncol 2020; 31 (07) 961-964
    CrossrefPubMedGoogle Scholar
  • 44 Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol 2020; 2 (05) e255-e256
    CrossrefPubMedGoogle Scholar
  • 45 Castiglione V, Chiriacò M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID-19 infection. Eur Heart J Cardiovasc Pharmacother 2020; 42
    PubMedGoogle Scholar
  • 46 Dashti-Khavidaki S, Khalili H. Considerations for statin therapy in patients with COVID-19. Pharmacotherapy 2020; 40 (05) 484-486
    CrossrefPubMedGoogle Scholar
  • 47 Virani SS. Is There a Role For Statin Therapy in Acute Viral Infections? Cardiology Magazine; 2020. Available at: https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/09/is-there-a-role-for-statin-therapy-in-acute-viral-infections-covid-19. Accessed July 9, 2020
    PubMed
  • 48 Zhang W, Zhao Y, Zhang F. et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol 2020; 214: 108393
    CrossrefPubMedGoogle Scholar
  • 49 Stebbing J, Phelan A, Griffin I. et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020; 20 (04) 400-402
    CrossrefPubMedGoogle Scholar
  • 50 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135 (23) 2033-2040
    CrossrefPubMedGoogle Scholar
  • 51 Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke 2020; 51 (06) 1891-1895
    CrossrefPubMedGoogle Scholar
  • 52 Neurointervention Committee of the Chinese Medical Doctor Association. Recommendation of experts on prevention and control of new coronavirus infection in neurointerventional specialty (version 1) [D]. Chin J Cerebrovasc Dis 2020; 17: 107-112
    PubMedGoogle Scholar
  • 53 Powers WJ, Rabinstein AA, Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50 (12) e344-e418
    CrossrefPubMedGoogle Scholar
  • 54 Sharma D, Rasmussen M, Han R. et al. Anesthetic management of endovascular treatment of acute ischemic stroke during COVID-19 pandemic: consensus statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC): endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), European Society of Minimally Invasive Neurological Therapy (ESMINT) and American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) Cerebrovascular Section. J Neurosurg Anesthesiol 2020; 32 (03) 193-201
    CrossrefPubMedGoogle Scholar
  • 55 COVID-19: Statement Regarding the Management of Minimal, Mild and Moderate Head Injury. 2020. Available at: http://media.neurotrauma.nu/2020/03/SNC-statement-COVID-19.pdf. Accessed June 15, 2020
    PubMed
  • 56 Carney N, Totten AM, O’Reilly C. et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 2017; 80: 6-15
    CrossrefPubMedGoogle Scholar
  • 57 Korupolu R, Stampas A, Gibbons C, Hernandez Jimenez I, Skelton F, Verduzco-Gutierrez M. COVID-19: screening and triage challenges in people with disability due to Spinal Cord Injury. Spinal Cord Ser Cases 2020; 6 (01) 35
    CrossrefPubMedGoogle Scholar
  • 58 Dicks MA, Clements ND, Gibbons CR, Verduzco-Gutierrez M, Trbovich M. Atypical presentation of Covid-19 in persons with spinal cord injury. Spinal Cord Ser Cases 2020; 6 (01) 38
    CrossrefPubMedGoogle Scholar
  • 59 Rodríguez-Cola M, Jiménez-Velasco I, Gutiérrez-Henares F. et al. Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury. Spinal Cord Ser Cases 2020; 6 (01) 39
    CrossrefPubMedGoogle Scholar
  • 60 Stillman MD, Capron M, Alexander M, Di Giusto ML, Scivoletto G. COVID-19 and spinal cord injury and disease: results of an international survey. Spinal Cord Ser Cases 2020; 6 (01) 21
    CrossrefPubMedGoogle Scholar
  • 61 Basics guidance on management of spinal cord injury patients during coronavirus (COVID-19) pandemic. 2020. Available at: https://www.iscos.org.uk/uploads/CV-19/updated%20files%204%2024%2020/ENG_Basic_guidance_on_management.pdf. Accessed June 16, 2020
    PubMed
  • 62 Craen A, Logan G, Ganti L. Novel coronavirus disease 2019 and subarachnoid hemorrhage: a case report. Cureus 2020; 12 (04) e7846
    PubMedGoogle Scholar
  • 63 Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental?. New Microbes New Infect 2020; 35: 100669
    CrossrefPubMedGoogle Scholar
  • 64 COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARSCoV- 2 infection: an international cohort study. Lancet 2020. Doi: 10.1016/S0140-6736(20)31182-X
    PubMed
  • 65 Vollono C, Rollo E, Romozzi M. et al. Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure 2020; 78: 109-112
    CrossrefPubMedGoogle Scholar
  • 66 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223) 497-506
    CrossrefPubMedGoogle Scholar
  • 67 Kim JE, Heo JH, Kim HO. et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017; 13 (03) 227-233
    CrossrefPubMedGoogle Scholar
  • 68 Sharma K, Tengsupakul S, Sanchez O, Phaltas R, Maertens P. Guillain-Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: a case report. SAGE Open Med Case Rep 2019; 7: X19838750
    PubMedGoogle Scholar
  • 69 Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol 2020; 19 (05) 383-384
    CrossrefPubMedGoogle Scholar
  • 70 Elavarasi A, Goyal V. Hydroxychloroquine and myasthenia gravis-can one take this risk?. Ann Indian Acad Neurol 2020; 23: 360-361
    CrossrefPubMedGoogle Scholar
  • 71 Varan O, Kucuk H, Tufan A. Myasthenia gravis due to hydroxychloroquine. Reumatismo 2015; 67 (03) 849
    PubMedGoogle Scholar
  • 72 Klimek A. The myasthenic syndrome after chloroquine [in Polish]. Neurol Neurochir Pol 1999; 33 (04) 951-954
    PubMedGoogle Scholar
  • 73 Myles PS, Maswime S. Mitigating the risks of surgery during the COVID-19 pandemic. Lancet 2020; 396 (10243) 2-3
    CrossrefPubMedGoogle Scholar
  • 74 Aminian A, Safari S, Razeghian-Jahromi A, Ghorbani M, Delaney CP. COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period. Ann Surg 2020; 272 (01) e27-e29
    CrossrefPubMedGoogle Scholar
  • 75 Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020; 18 (06) 1421-1424
    CrossrefPubMedGoogle Scholar
  • 76 Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA. et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost 2020; 18 (06) 1517-1519
    CrossrefPubMedGoogle Scholar
  • 77 Goyal P, Choi JJ, Pinheiro LC. et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020; 382 (24) 2372-2374
    CrossrefPubMedGoogle Scholar
  • 78 Klok FA, Kruip MJHA, van der Meer NJM. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 2020; 191: 148-150
    CrossrefPubMedGoogle Scholar
  • 79 Lodigiani C, Iapichino G, Carenzo L. et al. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9-14
    CrossrefPubMedGoogle Scholar
  • 80 Poissy J, Goutay J, Caplan M, et al; Lille ICU Haemostasis COVID-19 group. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 2020. Doi:10.1161/CIRCULATIONAHA.120.047430
    PubMed
  • 81 Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020; 18 (05) 1094-1099
    CrossrefPubMedGoogle Scholar
  • 82 Wang T, Chen R, Liu C. et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol 2020; 7 (05) e362-e363
    CrossrefPubMedGoogle Scholar
  • 83 World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. World Health Organization; 2020. Available at: https://apps.who.int/iris/handle/10665/330893. Accessed January 28, 2020
    PubMed
  • 84 Dogra S, Jain R, Cao M, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis 2020. Doi:10.1016/j.jstrokecerebrovasdis.2020.104984
    PubMed
  • 85 Barazzoni R, Bischoff SC, Breda J. et al. endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr 2020; 39 (06) 1631-1638
    CrossrefPubMedGoogle Scholar
  • 86 Saez de la Fuente I, Saez de la Fuente J, Quintana Estelles MD. et al. Enteral nutrition in patients receiving mechanical ventilation in a prone position. J Parenter Enteral Nutr 2016; 40 (02) 250-255
    CrossrefPubMedGoogle Scholar
  • 87 National Tracheostomy Safety Project. Considerations for tracheostomy in the COVID-19 outbreak. 2020. Available at: https://icmanaesthesiacovid-19.org/considerations-for-tracheostomy-in-the-covid-19-outbreak. Accessed June 13, 2020
    PubMed
  • 88 Shiba T, Ghazizadeh S, Chhetri D, St John M, Long J. Tracheostomy considerations during the COVID-19 pandemic. OTO Open 2020; 4 (02) X20922528
    CrossrefPubMedGoogle Scholar
  • 89 MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA 2020. Doi: 10.1001/jama.2020.2342
    PubMed
  • 90 Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA 2019; 321 (12) 1200-1210
    CrossrefPubMedGoogle Scholar
  • 91 Edelson DP, Sasson C, Chan PS. et al. American Heart Association ECC Interim COVID Guidance Authors. Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID-19: from the Emergency Cardiovascular Care Committee and Get With The Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association. Circulation 2020; 141 (25) e933-e943
    CrossrefPubMedGoogle Scholar